ArticleFrontiers in oncology2020

Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib.

Anja Charlotte Lundgren Mortensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.